Structure-function analysis of the short splicing variant carboxypeptidase encoded by Drosophila melanogaster silver

Journal of Molecular Biology

Volumn 401, Issue 3, 2010, Pages 465-477

  Tanco, Sebastián ^a   Arolas, Joan L ^a,b   Guevara, Tibisay ^b   Lorenzo, Julia ^a   Avilés, Francesc X ^a   Gomis Rüth, F Xavier ^b  

^a UNIVERSITAT AUTÒNOMA DE BARCELONA   (Spain)

^b INSTITUT DE BIOLOGIA MOLECULAR DE BARCELONA   (Spain)

Author keywords

Activity regulation; Development; Funnelin; Metallocarboxypeptidase; Splicing variant

Indexed keywords

CARBOXYPEPTIDASE; ENZYME VARIANT; HOMODIMER; HYDROLASE; MEMBRANE PROTEIN; METALLOPROTEINASE; MONOMER; PEPTIDASE; PREALBUMIN; CARBOXYPEPTIDASE D; CYSTEINE; ISOPROTEIN; PEPTIDE HYDROLASE;

AMINO TERMINAL SEQUENCE; ARTICLE; CARBOXY TERMINAL SEQUENCE; CRYSTAL STRUCTURE; DROSOPHILA MELANOGASTER; ENZYME ACTIVE SITE; ENZYME ACTIVITY; ENZYME LOCALIZATION; ENZYME STRUCTURE; ENZYME SUBSTRATE; EXON; GENETIC CODE; NONHUMAN; NUCLEOTIDE SEQUENCE; ORTHOLOGY; PRIORITY JOURNAL; PROTEIN CONFORMATION; PROTEIN DEGRADATION; PROTEIN DOMAIN; RNA GENE; RNA SPLICING; SECRETORY PATHWAY; SILVER GENE; ANIMAL; CHEMISTRY; ENZYMOLOGY; GENETICS; METABOLISM; PROTEIN MULTIMERIZATION; X RAY CRYSTALLOGRAPHY;

ALIAS; DROSOPHILA MELANOGASTER; MAMMALIA; VERTEBRATA;

ANIMALS; CARBOXYPEPTIDASES; CRYSTALLOGRAPHY, X-RAY; CYSTEINE; DROSOPHILA MELANOGASTER; PEPTIDE HYDROLASES; PROTEIN CONFORMATION; PROTEIN ISOFORMS; PROTEIN MULTIMERIZATION;

EID: 77955281659     PISSN: 00222836     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jmb.2010.06.035     Document Type: Article

References (68)

1. Morgan T.H., Bridges C.B., Sturtevant A.H. The genetics of Drosophila. Bibliogr. Genet. 1925, 2:1-262.
2. Lindsley D.L., Zimm G.G. The Genome of Drosophila melanogaster 1992, Academic Press, Inc., San Diego, CA.
3. Settle S.H., Green M.M., Burtis K.C. The silver gene of Drosophila melanogaster encodes multiple carboxypeptidases similar to mammalian prohormone-processing enzymes. Proc. Natl Acad. Sci. USA 1995, 92:9470-9474.
4. Tweedie S., Ashburner M., Falls K., Leyland P., McQuilton P., Marygold S., et al. FlyBase: enhancing Drosophila Gene Ontology annotations. Nucleic Acids Res. 2009, 37:D555-D559. (Database issue).
5. Sidyelyeva G., Baker N.E., Fricker L.D. Characterization of the molecular basis of the Drosophila mutations in carboxypeptidase D. Effect on enzyme activity and expression. J. Biol. Chem. 2006, 281:13844-13852.
6. Sidyelyeva G., Fricker L.D. Characterization of Drosophila carboxypeptidase D. J. Biol. Chem. 2002, 277:49613-49620.
7. Song L., Fricker L.D. Purification and characterization of carboxypeptidase D, a novel carboxypeptidase E-like enzyme, from bovine pituitary. J. Biol. Chem. 1995, 270:25007-25013.
8. Song L., Fricker L.D. Tissue distribution and characterization of soluble and membrane-bound forms of metallocarboxypeptidase D. J. Biol. Chem. 1996, 271:28884-28889.
9. Arolas J.L., Vendrell J., Aviles F.X., Fricker L.D. Metallocarboxypeptidases: emerging drug targets in biomedicine. Curr. Pharm. Des. 2007, 13:349-366.
10. Fricker L.D. Carboxypeptidases D and E. The Enzymes. Co- and Posttranslational Proteolysis of Proteins 2002, vol. 23:421-452. Academic Press, Inc., London, UK. R.E. Dalbey, D.S. Sigman (Eds.).
11. Skidgel R.A., Erdös E.G. Cellular carboxypeptidases. Immunol. Rev. 1998, 161:129-141.
12. Fricker L.D. 251. Metallocarboxypeptidase D. Handbook of Proteolytic Enzymes 2004, vol. 1:848-851. Elsevier, London, UK, 2 vols. 2nd edit. A.J. Barrett, N.D. Rawlings, J.F. Woessner (Eds.).
13. Sidyelyeva G., Wegener C., Schoenfeld B.P., Bell A.J., Baker N.E., McBride S.M., Fricker L.D. Individual carboxypeptidase D domains have both redundant and unique functions in Drosophila development and behavior. Cell. Mol. Life Sci. 2010, In press. doi:10.1007/s00018-010-0369-8.
14. Abdelmagid S.A., Too C.K. Prolactin and estrogen up-regulate carboxypeptidase-D to promote nitric oxide production and survival of mcf-7 breast cancer cells. Endocrinology 2008, 149:4821-4828.
15. Hadkar V., Skidgel R.A. Carboxypeptidase D is up-regulated in raw 264.7 macrophages and stimulates nitric oxide synthesis by cells in arginine-free medium. Mol. Pharmacol. 2001, 59:1324-1332.
16. Gomis-Rüth F.X. Structure and mechanism of metallocarboxypeptidases. Crit. Rev. Biochem. Mol. Biol. 2008, 43:319-345.
17. Rawlings N.D., Barrett A.J., Bateman A. MEROPS: the peptidase database. Nucleic Acids Res. 2010, 38:D227-D233.
18. Skidgel R.A. Basic carboxypeptidases: regulators of peptide hormone activity. Trends Pharmacol. Sci. 1988, 9:299-304.
19. Skidgel R.A. Structure and function of mammalian zinc carboxypeptidases. Zinc Metalloproteases in Health and Disease 1996, 241-283. Taylor and Francis Ltd., London, UK. N.M. Hooper (Ed.).
20. Skidgel R.A. 252. Carboxypeptidase M. Handbook of Proteolytic Enzymes 2004, vol. 1:851-854. Elsevier, London, UK, 2 vols. 2nd edit. A.J. Barrett, N.D. Rawlings, J.F. Woessner (Eds.).
21. Gomis-Rüth F.X., Companys V., Qian Y., Fricker L.D., Vendrell J., Avilés F.X., Coll M. Crystal structure of avian carboxypeptidase D domain II: a prototype for the regulatory metallocarboxypeptidase subfamily. EMBO J. 1999, 18:5817-5826.
22. Reznik S.E., Fricker L.D. Carboxypeptidases from A to Z: implications in embryonic development and Wnt binding. Cell. Mol. Life Sci. 2001, 58:1790-1804.
23. Kuroki K., Cheung R., Marion P.L., Ganem D. A cell surface protein that binds avian hepatitis B virus particles. J. Virol. 1994, 68:2091-2096.
24. Eng F.J., Novikova E.G., Kuroki K., Ganem D., Fricker L.D. gp180, a protein that binds duck hepatitis B virus particles, has metallocarboxypeptidase D-like enzymatic activity. J. Biol. Chem. 1998, 273:8382-8388.
25. Gomis-Rüth F.X. Catalytic domain architecture of metzincin metalloproteases. J. Biol. Chem. 2009, 15353-15357.
26. Li F., Li W., Farzan M., Harrison S.C. Structure of SARS coronavirus spike receptor-binding domain complexed with receptor. Science 2005, 309:1864-1868.
27. Wright T.R.F. The genetics of biogenic amine metabolism, sclerotization, and melanization in Drosophila melanogaster. Adv. Genet. 1987, 24:127-222.
28. De Schutter K., Lin Y.C., Tiels P., Van Hecke A., Glinka S., Weber-Lehmann J., et al. Genome sequence of the recombinant protein production host Pichia pastoris. Nat. Biotechnol. 2009, 27:561-566.
29. Rawlings N.D., Morton F.R., Kok C.Y., Kong J., Barrett A.J. MEROPS: the peptidase database. Nucleic Acids Res. 2008, 36:D320-D325. (Database issue).
30. Ungar D. Golgi linked protein glycosylation and associated diseases. Semin. Cell Dev. Biol. 2009, 20:762-769.
31. Valnickova Z., Thaysen-Andersen M., Hojrup P., Christensen T., Sanggaard K.W., Kristensen T., Enghild J.J. Biochemical characterization of bovine plasma thrombin-activatable fibrinolysis inhibitor (TAFI). BMC Biochem. 2009, 10:13.
32. Fricker L.D., Devi L. Comparison of a spectrophotometric, a fluorometric, and a novel radiometric assay for carboxypeptidase E (EC 3.4.17.10) and other carboxypeptidase B-like enzymes. Anal. Biochem. 1990, 184:21-27.
33. Deiteren K., Surpateanu G., Gilany K., Willemse J.L., Hendriks D.F., Augustyns K., et al. The role of the S1 binding site of carboxypeptidase M in substrate specificity and turn-over. Biochim. Biophys. Acta 2007, 1774:267-277.
34. McKay T.J., Phelan A.W., Plummer T.H. Comparative studies on human carboxypeptidases B and N. Arch. Biochem. Biophys. 1979, 197:487-492.
35. Arolas J.L., Lorenzo J., Rovira A., Castella J., Aviles F.X., Sommerhoff C.P. A carboxypeptidase inhibitor from the tick Rhipicephalus bursa: isolation, cDNA cloning, recombinant expression, and characterization. J. Biol. Chem. 2005, 280:3441-3448.
36. Marx P.F., Brondijk T.H., Plug T., Romijn R.A., Hemrika W., Meijers J.C., Huizinga E.G. Crystal structures of TAFI elucidate the inactivation mechanism of activated TAFI: a novel mechanism for enzyme autoregulation. Blood 2008, 112:2803-2809.
37. Ollis D.L., Cheah E., Cygler M., Dijkstra B., Frolow F., Franken S.M., et al. The α/β hydrolase fold. Protein Eng. 1992, 5:197-211.
38. Puente X.S., López-Otín C. The PLEES proteins-a family of structurally related enzymes widely distributed from bacteria to humans. Biochem. J. 1997, 332:947-949.
39. Bayés A., Fernández D., Solà M., Marrero A., García-Piqué S., Avilés F.X., et al. Caught after the act: a human A-type metallocarboxypeptidase in a product complex with a cleaved hexapeptide. Biochemistry 2007, 46:6921-6930.
40. Reverter D., Maskos K., Tan F., Skidgel R.A., Bode W. Crystal structure of human carboxypeptidase M, a membrane-bound enzyme that regulates peptide hormone activity. J. Mol. Biol. 2004, 338:257-269.
41. Keil C., Maskos K., Than M., Hoopes J.T., Huber R., Tan F., et al. Crystal structure of the human carboxypeptidase N (kininase I) catalytic domain. J. Mol. Biol. 2007, 366:504-516.
42. Prapunpoj P., Leelawatwattana L. Evolutionary changes to transthyretin: structure-function relationships. FEBS J. 2009, 276:5330-5341.
43. Nooren I.M.A., Thornton J.M. Structural characterisation and functional significance of transient protein-protein interactions. J. Mol. Biol. 2003, 325:991-1018.
44. Skidgel R.A., Erdös E.G. Structure and function of human plasma carboxypeptidase N, the anaphylatoxin inactivator. Int. Immunopharmacol. 2007, 7:1888-1899.
45. McCall K.A., Huang C., Fierke C.A. Function and mechanism of zinc metalloenzymes. J. Nutr. 2000, 130:1437S-1446S.
46. Auld D.S. Zinc coordination sphere in biochemical zinc sites. BioMetals 2001, 14:271-313.
47. 2+ ligand in the catalytic mechanism of human glyoxalase I. J. Biol. Chem. 1998, 273:21623-21628.
48. Aloy P., Companys V., Vendrell J., Avilés F.X., Fricker L.D., Coll M., Gomis-Rüth F.X. The crystal structure of the inhibitor-complexed carboxypeptidase D domain II and the modeling of regulatory carboxypeptidases. J. Biol. Chem. 2001, 276:16177-16184.
49. Avilés F.X., Vendrell J., Guasch A., Coll M., Huber R. Advances in metallo-procarboxypeptidases. Emerging details on the inhibition mechanism and on the activation process. Eur. J. Biochem. 1993, 211:381-389.
50. Kalinina E.V., Fricker L.D. Palmitoylation of carboxypeptidase D. Implications for intracellular trafficking. J. Biol. Chem. 2003, 278:9244-9249.
51. Zappacosta F., Pessi A., Bianchi E., Venturini S., Sollazzo M., Tramontano A., et al. Probing the tertiary structure of proteins by limited proteolysis and mass spectrometry: the case of Minibody. Protein Sci. 1996, 5:802-813.
52. Llano E., Adam G., Pendas A.M., Quesada V., Sánchez L.M., Santamaria I., et al. Structural and enzymatic characterization of Drosophila Dm2-MMP, a membrane-bound matrix metalloproteinase with tissue-specific expression. J. Biol. Chem. 2002, 277:23321-23329.
53. Lyons P.J., Callaway M.B., Fricker L.D. Characterization of carboxypeptidase A6, an extracellular matrix peptidase. J. Biol. Chem. 2008, 283:7054-7063.
54. Lin Q., Yu N.J., Spremulli L.L. Expression and functional analysis of Euglena gracilis chloroplast initiation factor 3. Plant Mol. Biol. 1996, 32:937-945.
55. Barbosa Pereira P.J., Segura-Martin S., Oliva B., Ferrer-Orta C., Avilés F.X., Coll M., et al. Human procarboxypeptidase B: three-dimensional structure and implications for thrombin-activatable fibrinolysis inhibitor (TAFI). J. Mol. Biol. 2002, 321:537-547.
56. Fricker L.D., Snyder S.H. Purification and characterization of enkephalin convertase, an enkephalin-synthesizing carboxypeptidase. J. Biol. Chem. 1983, 258:10950-10955.
57. Pallarès I., Bonet R., García-Castellanos R., Ventura S., Avilés F.X., Vendrell J., Gomis-Rüth F.X. Structure of human carboxypeptidase A4 with its endogenous protein inhibitor, latexin. Proc. Natl Acad. Sci. USA 2005, 102:3978-3983.
58. Sanglas L., Aviles F.X., Huber R., Gomis-Ruth F.X., Arolas J.L. Mammalian metallopeptidase inhibition at the defense barrier of Ascaris parasite. Proc. Natl Acad. Sci. USA 2009, 106:1743-1747.
59. Kabsch W. Chapter 25.2.9: XDS. International Tables for Crystallography. Volume F: Crystallography of Biological Macromolecules 2001, 730-734. Kluwer Academic Publishers (for The International Union of Crystallography), Dordrecht, The Netherlands. 1st edit. M.G. Rossmann, E. Arnold (Eds.).
60. Evans P. Scaling and assessment of data quality. Acta Crystallogr., Sect. D: Biol. Crystallogr. 2006, 62:72-82.
61. Mallorquí-Fernández N., Manandhar S.P., Mallorquí-Fernández G., Usón I., Wawrzonek K., Kantyka T., et al. A new autocatalytic activation mechanism for cysteine proteases revealed by Prevotella intermedia interpain A. J. Biol. Chem. 2008, 283:2871-2882.
62. Davis I.W., Leaver-Fay A., Chen V.B., Block J.N., Kapral G.J., Wang X., et al. MolProbity: all-atom contacts and structure validation for proteins and nucleic acids. Nucleic Acids Res. 2007, 35:W375-W383. (Web Server issue).
63. Adams P.D., Grosse-Kunstleve R.W., Hung L.W., Ioerger T.R., McCoy A.J., Moriarty N.W., et al. PHENIX: building new software for automated crystallographic structure determination. Acta Crystallogr., Sect. D: Biol. Crystallogr. 2002, 58:1948-1954.
64. McCoy A.J., Grosse-Kunstleve R.W., Adams P.D., Winn M.D., Storoni L.C., Read R.J. Phaser crystallographic software. J. Appl. Crystallogr. 2007, 40:658-674.
65. Carranza C., Inisan A.G., Mouthuy-Knoops E., Cambillau C., Roussel A. Turbo-Frodo. AFMB Activity Report 1996-1999 1999, 89-90. CNRS-UPR 9039, Marseille, France.
66. Evans S.V. SETOR: hardware lighted three-dimensional solid model representations of macromolecules. J. Mol. Graphics 1993, 11:134-138.
67. Vriend G. WHAT IF: a molecular modelling and drug design program. J. Mol. Graphics 1990, 8:52-56.
68. Thompson J.D., Higgins D.G., Gibson T.J. CLUSTAL W: improving the sensitivity of progressive multiple sequence alignment through sequence weighting, position-specific gap penalties and weight matrix choice. Nucleic Acids Res. 1994, 22:4673-4680.